english
stringlengths 2
1.37k
|
---|
European Medicines Agency
|
4.3 Contraindications
|
Common
|
avamys
|
M05BB03.
|
螘位位维未伪 Roche (Hellas) A. E.
|
3.
|
In reproductive toxicology studies in which animals were administered entecavir for up to 4 weeks, no evidence of impaired fertility was seen in male or female rats at high exposures.
|
Although specific interactions have not been studied, other protease inhibitors, such as saquinavir, and other CYP3A4 inhibitors, such as erythromycin, clarithromycin, itraconazole and grapefruit juice should be co-administered with caution as they would be expected to increase plasma concentrations of tadalafil (see section 4.4).
|
These symptoms can constitute an early
|
analyse leakage; see Important information about BEROMUN, below)
|
Less commonly patients have reported infections, strange taste, cataracts, bundle branch block, tooth disorder, skin problems, aching joints, arthritis, and thirst.
|
Renal impairment:
|
0.5 ml
|
INSTRUCTIONS ON USE
|
For a recovery 0.7 IU/ dl (average increase of factor IX), then:
|
Monitoring of cardiac and vital signs is recommended, along with appropriate symptomatic and supportive measures.
|
100 unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
|
- muscle stiffness (hypertonia), painful muscles (myalgia), muscular debility (myasthenia), back
|
Tel: + 420 222 001 111 gsk.czmail@gsk.com
|
Tardive Dyskinesia: in clinical trials of one year or less duration, there were uncommon reports of treatment emergent dyskinesia during treatment with aripiprazole.
|
If you have any further questions on the use of this product, ask your doctor or pharmacist.
|
LIST OF EXCIPIENTS
|
Treatment of symptomatic anaemia in adult and paediatric chronic renal failure patients
|
Insulin glulisine
|
10 mg
|
One vial of 5 ml contains 250 micrograms of palonosetron 50 micrograms/ ml (as hydrochloride)
|
Treatment of diabetes mellitus.
|
Following any confirmed or suspected overdose with aripiprazole, close medical supervision and monitoring should continue until the patient recovers.
|
Steady-state plasma concentrations are attained within 3 days after initiation of a once-daily dosing regimen.
|
Development of inhibitors is a known complication in the treatment of haemophilia A.
|
Slovensk谩 republika GlaxoSmithKline Slovakia s. r. o.
|
8.
|
EXP:
|
NAME OF THE MEDICINAL PRODUCT
|
Blood uric acid levels were measured every month.
|
Half-life was also similar between adult and paediatric patients with CRF following both intravenous and subcutaneous administration.
|
4.4 Special warnings and precautions for use
|
You get a hypo if your blood sugar gets too low.
|
DK-2900 Hellerup Tlf: +45-35 25 35 50
|
Reproduction is authorised provided the source is acknowledged.
|
Paediatric patients
|
8
|
NAME OF THE MEDICINAL PRODUCT
|
The Committee recommended that Cancidas be given marketing authorisation.
|
15 January 2006
|
In infants and toddlers aged 6 to 23 months, the most frequent adverse events reported in excess of placebo were diarrhoea (3.7%), fever (2.3%) and insomnia (2.3%).
|
Ireland Biogen Idec (Ireland) Ltd. +353 (0)1 463 7799
|
15.
|
METHOD AND ROUTE(S) OF ADMINISTRATION
|
In paediatric patients the recommended target haemoglobin range is between 9.5 and 11 g/ dl (5.9 - 6.8 mmol/ l).
|
(7.8 - 10.7)
|
Common side effects are heartburn, indigestion, diarrhoea, stomach ache, nausea and flatulence.
|
Hb between 9.5 and 11 g/ dl (5.9 - 6.8 mmol/ l).
|
Subcutaneous tolerance studies indicate that Caelyx, as against standard doxorubicin hydrochloride, causes slighter local irritation or damage to the tissue after a possible extravasation.
|
Please discuss this with your doctor.
|
Due to its increased carbohydrate content darbepoetin alfa has a longer terminal half-life than r-HuEPO and consequently a greater
|
60 avoided; guidance for appropriate dose adjustment for when haemoglobin values exceeding 12 g/ dl (7.5 mmol/ l) are observed are described below.
|
Myocardial Ischaemia The available data indicate that treatment with rosiglitazone may be associated with an increased risk of myocardial ischaemic events (see section 4.8).
|
If you are receiving this medicine by subcutaneous injection, your doctor may suggest that you learn how to give yourself the injections.
|
Hypoglycaemia may occur if the insulin dose is too high in relation to the insulin requirement (see sections 4.8 and 4.9).
|
If the patient is already receiving nonsteroidal anti-inflammatory drugs (NSAIDs) and/ or corticosteroids, these may be continued after starting leflunomide.
|
Its levels in the blood normally increase after the onset of darkness and peak in the middle of the night to promote sleep.
|
Arthralgia Myalgia Back pain General System disorders
|
EU/ 1/ 08/ 450/ 007
|
DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION
|
What is Avandia?
|
4.2 Posology and method of administration
|
STATEMENT OF ACTIVE SUBSTANCE(S)
|
What ABILIFY contains The active substance is aripiprazole.
|
Azomyr 0.5 mg/ ml oral solution desloratadine
|
4.
|
6.
|
Therefore this combination is not recommended (see section 4.4).
|
A short alpha-phase occurs immediately post-infusion, followed by a beta-phase with a half- life of 9 to 11 hours.
|
Calcium containing solutions should not be mixed with Bondronat concentrate for solution for infusion.
|
Tell your doctor if you are or think you may be pregnant or if you are breast-feeding.
|
A.
|
Such conditions should be corrected before the administration of Aprovel.
|
alli 60 mg hard capsules:
|
METHOD AND ROUTE(S) OF ADMINISTRATION
|
30 film-coated tablets 60 film-coated tablets 90 film-coated tablets Multipack containing 180 (2 packs of 90) film-coated tablets
|
Azomyr 2.5 mg orodispersible tablets desloratadine
|
Tell your doctor or pharmacist if you feel discomfort when using the spray.
|
Preliminary information suggests a relationship may exist between the presence of major deletion mutations in a patient's factor IX gene and an increased risk of inhibitor formation and of acute hypersensitivity reactions.
|
GlaxoSmithKline Biologicals s.a.
|
Common:
|
IMPORTANT INFORMATION ABOUT YOUR BYETTA PEN
|
Cartons of 56 x 1 film-coated tablet; 7 blister cards of 8 x 1 film-coated tablet each in PVC/ PVDC/ Aluminium perforated unit dose blisters.
|
15.
|
This regimen reduced the occurrence of new radiographic vertebral fractures by 62% (p=0.0001) over the three year duration of the study.
|
Children and adolescents:
|
Agitation, confusional state, depression, anxiety, thinking abnormal, insomnia
|
Treatment:
|
LIST OF EXCIPIENTS
|
75 14.
|
In a study in which leflunomide was given concomitantly with a triphasic oral contraceptive pill containing 30 碌g ethinyloestradiol to healthy female volunteers, there was no reduction in contraceptive activity of the pill, and A771726 pharmacokinetics were within predicted ranges.
|
For preventing recurrence of manic episodes in patients who have been receiving aripiprazole, continue therapy at the same dose.
|
Disorders of the nerves and senses such as convulsions, tremor, dizziness, depression, drowsiness, numbness, muscle spasms, anxiety, changes in thinking or mood.
|
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
|